Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoking Cessation in Young Adult Dual Users
NCT04946825Phase 2Completed
- Sponsor
- The University of Vermont
- Start
- Jun 2021
- Primary completion
- Aug 2023
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (4 arms), sponsored by The University of Vermont. Primary endpoints: Biochemically Confirmed 7-day Point-prevalence Cigarette Abstinence at 3 months, Self-reported 7-day Point-prevalence Cigarette Abstinence at 3 months and 1 more. Started Jun 2021; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04946825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04946825.